Schumacher Electric Corporation Launches Rugged Lithium Ion Jump Starter
3.11.2021 11:03:00 EET | Business Wire | Press release
Schumacher Electric Corporation, the global leader of automotive aftermarket power conversion products, has introduced its new Rugged Lithium Ion Jump Starter series to the United States and European markets. Available in 1000, 1500, 2000 and 2500 peak amps, these jump starters are powerful, portable and compact, and can safely start a dead battery in seconds. The line will be available online and in select retailers.
“Our national lithium jump starter launch times perfectly for winterization preparations as the jump starters feature pre-heating technology to warm batteries in extreme cold,” said Mickey Leech, CEO at Schumacher Electric Corporation. “It’s also the perfect holiday gift for all drivers in your family or simply the person who has it all because of its multi-use design that includes the ability to charge a variety of USB devices. As we move towards our 75th company anniversary in 2022, we will continue to bring new, innovative products to market and set Schumacher apart from its competitors.”
Key features of the Schumacher Rugged Lithium Ion Jump Starter Product Line:
Schumacher 1000 Peak Amp Rugged Lithium Ion Jump Starter
- 1000 peak amps
- 25 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 6.0L gas and 3.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 1500 Peak Amp Rugged Lithium Ion Jump Starter
- 1500 peak amps
- 35 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 8.0L gas and 6.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2000 Peak Amp Rugged Lithium Ion Jump Starter
- 2000 peak amps
- 45 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2500 Peak Amp Rugged Lithium Ion Jump Starter
- 2500 peak amps
- 50 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster
- 2.4A USB charges devices twice as fast via powered USB port
- LED area light
“We are pleased to bring top-of-the-line lithium jump starter products to market that are not only powerful but designed with ease-of-use in mind,” said Dirk Kuyckx, general manager of Schumacher Europe. “We wanted to offer a variety of products with unique features to meet the needs of all consumers and standout in a crowded market. Whether it’s a car, van, SUV, boat or recreational vehicle, our lithium jump starter has a durable rugged design with pre-boost technology for bringing even deeply discharged batteries back to life.”
About Schumacher Electric Corporation
Schumacher Electric Corporation is known for industry-leading innovation, an unwavering commitment to quality, and providing feature-rich products that represent a remarkable value and price. For nearly 75 years, Schumacher has been powering lifestyles with a legacy centered on delivering product excellence and exceptional service to customers with a broad range of needs and experience levels. Put your trust in a Schumacher.
To learn more visit: www.schumacherelectric.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005155/en/
Contact information
Chelsi Smith
Pierpont Communications
956-358-3300 (C)
csmith@piercom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom